The introduction of HB 0143 significantly alters existing state laws regarding marijuana use and regulation. It allows patients with specific debilitating medical conditions to acquire and use medical marijuana, provided they have valid medical marijuana certifications issued by qualified health care providers. This change not only facilitates access to potentially beneficial treatments for qualifying patients but also introduces a system for monitoring and testing the safety and effectiveness of medical marijuana products. Opponents of the bill, however, may raise concerns about the potential for misuse or inadequate oversight of marijuana-related establishments.
Summary
House Bill 0143, also known as the Wyoming Patient Cannabis Act of 2022, aims to establish a regulated framework for the use of medical marijuana within the state. The bill allows for the acquisition, growth, cultivation, extraction, production, processing, manufacture, and retail sale of medical marijuana and its derived products. Furthermore, it defines various medical marijuana establishments, such as cultivation and manufacturing facilities, and sets out robust rules for their licensing and operation. The Wyoming department of revenue liquor division will be responsible for the regulation and enforcement of these provisions, ensuring patient access while maintaining compliance with pertinent regulations.
Contention
While HB 0143 presents an organized approach to medical marijuana regulation, it may face contention regarding its comprehensive provisions. Some may argue that the bill's restrictions on the sale and use of marijuana-derived products could hinder patient access. Additionally, there is concern that the bill restricts local jurisdictions from enacting stricter regulations, possibly undermining local governance and control. Furthermore, discussions surrounding the inclusion of synthetic marijuana and the imposition of strict penalties for noncompliance have also emerged as notable points of debate among legislators and stakeholders.
Creating the medical cannabis pilot program act to establish the medical cannabis pilot program for limited cultivation, processing and dispensing of medical cannabis and medical cannabis products.
Creating the Kansas medical cannabis act to authorize the cultivation, processing, distribution, sale and use of medical cannabis and medical cannabis products and the Kansas cannabidiol regulation act to regulate the testing and retail sale of cannabidiol products.
AN ACT to amend Tennessee Code Annotated, Title 4; Title 29; Title 33; Title 38; Title 39; Title 40; Title 41; Title 43; Title 45; Title 50; Title 53; Title 57; Title 63; Title 67; Title 68 and Title 71, relative to the "Medical Autonomy Related to Cannabis Act."
AN ACT to amend Tennessee Code Annotated, Title 4; Title 29; Title 33; Title 38; Title 39; Title 40; Title 41; Title 43; Title 45; Title 50; Title 53; Title 57; Title 63; Title 67; Title 68 and Title 71, relative to the "Tennessee Medical Autonomy Related to Cannabis Act."
AN ACT to amend Tennessee Code Annotated, Title 4; Title 29; Title 33; Title 38; Title 39; Title 40; Title 41; Title 43; Title 45; Title 50; Title 53; Title 57; Title 63; Title 67; Title 68 and Title 71, relative to the "Tennessee Medical Autonomy Related to Cannabis Act."